Hill-Rom Holdings, Inc. (NYSE:HRC) posted its quarterly earnings data on Monday. The medical technology company reported $0.68 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.03, Marketbeat.com reports. The firm earned $661.20 billion during the quarter, compared to analysts’ expectations of $6.46 billion.

Shares of Hill-Rom Holdings (NYSE:HRC) opened at 48.88 on Monday. The stock’s 50 day moving average is $47.98 and its 200 day moving average is $51.82. The stock has a market cap of $3.19 billion and a price-to-earnings ratio of 59.61. Hill-Rom Holdings has a 52 week low of $45.20 and a 52 week high of $58.73.

HRC has been the subject of several analyst reports. Vetr upgraded shares of Hill-Rom Holdings from a “buy” rating to a “strong-buy” rating and set a $60.00 price objective for the company in a research note on Monday, October 5th. Zacks Investment Research lowered shares of Hill-Rom Holdings from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 30th. Northcoast Research upgraded shares of Hill-Rom Holdings from a “neutral” rating to a “buy” rating in a research note on Wednesday, December 16th. Finally, KeyBanc upgraded shares of Hill-Rom Holdings from a “sector weight” rating to an “overweight” rating and set a $59.00 price objective for the company in a research note on Thursday, January 21st. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Hill-Rom Holdings currently has a consensus rating of “Buy” and a consensus target price of $58.20.

Hill-Rom Holdings, Inc. (NYSE:HRC) is a medical technology company. The Company partners with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. The Company operates in three segments: North America, Surgical and Respiratory Care and International. North America segment sells and rents its patient support and near-patient technologies and services, as well as its clinical workflow solutions, in the United States and Canada. Surgical and Respiratory Care segment sells and rents its surgical and respiratory care products globally. International segment sells and rents similar products as its North America segment in regions outside of the United States and Canada.

12 Month Chart for NYSE:HRC

Receive News & Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.